CODEXIS INC
For the period ended Mar 31, 2025. Filed May 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 14, 2025
CDXS$1.11+2.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Statements of Operations
Condensed Consolidated Statements of Operations
(In Thousands, Except Per Share Amounts)
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Revenues: | ||
| Product revenue | $6,059 | $9,551 |
| Research and development revenue | 1,484 | 7,522 |
| Total revenues | 7,543 | 17,073 |
| Costs and operating expenses: | ||
| Cost of product revenue | 2,732 | 4,855 |
| Research and development | 12,942 | 11,246 |
| Selling, general and administrative | 12,355 | 12,860 |
| Total costs and operating expenses | 28,029 | 28,961 |
| Loss from operations | (20,486) | (11,888) |
| Interest income | 751 | 909 |
| Interest and other expense, net | (942) | (516) |
| Loss before income taxes | (20,677) | (11,495) |
| Provision for income taxes | 11 | 10 |
| Net loss | $(20,688) | $(11,505) |
| Net loss per share, basic and diluted | $(0.25) | $(0.16) |
| Weighted average common stock shares used in computing net loss per share, basic and diluted | 82,410 | 69,854 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.